INTERNATIONAL PATENT: JNANA THERAPEUTICS INC. FILES APPLICATION FOR "TREATING CHRONIC KIDNEY DISEASE WITH A COMBINATION OF SLC6A19 AND SGLT2 INHIBITORS"

GENEVA, Oct. 20 -- JNANA THERAPEUTICS INC. (One Design Center Place, Suite 19-400Boston, MA 02210) filed a patent application (PCT/US2025/024283) for "TREATING CHRONIC KIDNEY DISEASE WITH A COMBINATION OF SLC6A19 AND SGLT2 INHIBITORS" on Apr 11, 2025. With publication no. WO/2025/217520, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VRATSANOS, George (264 Castle DriveEnglewood Cliffs, NJ 07024), VIADER, Andreu (504 Essex StHamilton, MA 01982), WOBST, Heike, Julia (8 9th St., Apartment 803Medford, MA 02155), BROWN, Dean,...